NewsNovo
The headline figure is $19 million. (Nasdaq: MEDS) to reach it was $450,000, paid on September 11, 2026, to settle parallel litigation in Florida and Delaware.
The case for reading this as a decisive outcome is the spread between those two numbers.
What complicates it is that the $19 million is the company's own forward projection, not a closed accounting entry, and the dispute stretches back to a 2023 acquisition agreement that proved contentious on two separate fronts.
Both cases stemmed from a Membership Interest Purchase Agreement dated May 11, 2023, as amended. DataMEDS AI, based in Tampa, had filed in Florida state court against Brian Norton, Tony Madsen, Mark DiSiena, RxERP, Inc.
Keep reading